Australian medical imaging technology company 4DMedical (ASX: 4DX) came under selling pressure on 16 July 2026, with its shares falling 5.64% to AUD 3.68 in intraday trade around 1:56pm AEST (20-minute delayed data). The decline placed the stock among the weaker performers on the …
Biome Australia (ASX:BIO) drew investor interest after its shares climbed 7.69% to AUD 0.280 during trading on 16 July 2026. The consumer health company ranked among the day's notable ASX gainers, lifting its market capitalisation to approximately AUD 57.57mn. Trading turnover reached around 205,900 …
No single company-specific catalyst had been confirmed from the public disclosures reviewed for this article at the time of writing. The commentary below outlines what the company does, its position on the available snapshot metrics, the sector backdrop and the factors investors may wish …
No single company-specific catalyst had been confirmed from the public disclosures reviewed for this article at the time of writing. The commentary below outlines what the company does, its position on the available snapshot metrics, the sector backdrop and the factors investors may wish …
No single company-specific catalyst had been confirmed from the public disclosures reviewed for this article at the time of writing. The commentary below outlines what the company does, its position on the available snapshot metrics, the sector backdrop and the factors investors may wish …
No single company-specific catalyst had been confirmed from the public disclosures reviewed for this article at the time of writing. The commentary below explains Mesoblast’s business and pipeline, its reported financial position, the biotechnology backdrop and the factors investors may wish to watch — …
No single company-specific catalyst had been confirmed from the public disclosures reviewed for this article at the time of writing. The commentary below outlines what the company does, its position on the available snapshot metrics, the sector backdrop and the factors investors may wish …
Alterity Therapeutics (ASX:ATH) attracted investor attention after its shares rose 2.61% to AUD 0.590 during trading on 16 July 2026. The biotechnology company featured among the day's ASX gainers, lifting its market capitalisation to approximately AUD 130.55mn. Trading turnover reached around 11,610 shares, remaining …
Australian Clinical Labs (ASX: ACL) drew investor attention after its shares climbed 5.73% to AUD 2.40 during trading on 16 July 2026. The move placed the company among the day's notable ASX gainers, taking its market capitalisation to approximately AUD 427.13mn. Trading turnover reached …
PolyNovo Ltd (ASX:PNV) traded higher during the afternoon trading session on 16 July 2026, with its shares rising 2.00% to AUD 1.02. While the latest session reflected positive investor sentiment, the stock remains 15.00% lower over the past year, highlighting the importance of viewing …